Joseph Ojile is a Respiratory physician affiliated with Clayton Sleep Institute. OpenAlex indexes 40 publications with 1,001 citations (h-index 10); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
11200 Tesson Ferry Rd
Suite 100
Saint Louis, MO 631236922
Telephone
314-849-1500Registry record last updated 4 Feb 2010.
Clinical trials
- MedCline Investigational Study for the Treatment of Mild OSA With Positional Therapy
Sponsor: Amenity Health, Inc.
- Amara View Benchmark Study
Sponsor: Philips Clinical & Medical Affairs Global
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
39 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Fisher & Paykel Healthcare LimitedProgram year20257 payments$36,323openpaymentsdata.cms.gov ↗
- Takeda Pharmaceuticals U.S.A., Inc.Program year202513 payments$11,399openpaymentsdata.cms.gov ↗
- Eli Lilly and CompanyProgram year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
56.4%Corticosteroid33.7%Trelegy Ellipta59%Breo Ellipta15%Breztri Aerosphere13%Arnuity Ellipta6%Symbicort3%Budesonide-Formoterol Fumarate2%Fluticasone Propionate2%Pulmicort Flexhaler1%Part D<11 patientsbeta2-Adrenergic Agonist16.6%Albuterol Sulfate Hfa92%Ventolin Hfa8%Part D≥146 patients+ 3 more classes in this area
Nervous system
31.2%Benzodiazepine7.7%Clonazepam44%Alprazolam32%Lorazepam16%Temazepam8%Part D<11 patientsgamma-Aminobutyric Acid A Receptor Positive Modulator6.8%Zolpidem Tartrate95%Zolpidem Tartrate Er5%Part D<11 patients+ 10 more classes in this area
Anti-infectives
4.1%Macrolide Antimicrobial2.3%Azithromycin100%Part D≥39 patientsPenicillins with extended spectrum0.8%Amoxicillin50%Amoxicillin-Clavulanate Potass50%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Tim Driscoll
The University of Sydney
Francesco Saverio Violante
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola
Mark A. Rubin
University of Bern
Marc Humbert
Inserm
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”